Business

Baird Medical Showcases Advanced Ablation Technology at 2025 American Thyroid Association Annual Meeting

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, announced its successful participation in the 2025 American Thyroid Association (ATA) Annual Meeting. The event drew significant engagement from a global audience of physicians and researchers, reinforcing the growing international interest in the Company's innovative solutions.

articleBaird Medical Investment Holdings LtdSeptember 29, 20255/company/baird-medical-investment-holdings-limited/news/baird-medical-showcases-advanced-ablation-123000197
Baird Medical Showcases Advanced Ablation Technology at 2025 American Thyroid Association Annual Meeting

About this update from Baird Medical Investment Holdings Ltd

[{"type":"text","content":"NEW YORK, Sept. 29, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, announced its successful participation in the 2025 American Thyroid Association (ATA) Annual Meeting. The event drew significant engagement from a global audience of physicians and researchers, reinforcing the growing international interest in the Company's innovative solutions.","length":509,"tagName":"p"},{"type":"image","alt":"ATA 2025","displaySize":"","headline":null,"caption":"ATA 2025","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":273,"url":"https://media.zenfs.com/en/prnewswire.com/2e78e64d52115956e9beb8379cc0b2f6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/7w4rkytGRgtfvlb.m3_eiQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ4MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/2e78e64d52115956e9beb8379cc0b2f6","width":400,"height":273}},"href":"https://mma.prnewswire.com/media/2783978/ATA_2025.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The Company's exhibition booth served as a central hub for leading endocrinologists, surgeons, and researchers from the U.S., Europe, and South America. Attendees engaged in in-depth technical discussions and witnessed live demonstrations of Baird Medical's advanced MWA systems, highlighting the technology's precision and clinical utility.","length":353,"tagName":"p"},{"type":"text","content":"A key highlight of the conference was Baird Medical's Expo Theater session, which featured a presentation by Dr. Emad Kandil, Professor and Ellis Hanna Chair in Surgery at Tulane University School of Medicine. Moderated by Dr. Salem Noureldine from the George Washington University Medical Center, the session provided a comprehensive clinical overview of MWA. Dr. Kandil presented compelling data from his experience with over 200 MWA procedures. Crucially, his presentation detailed a cohort of 19 patients for whom MWA proved effective after previous Radiofrequency Ablation (RFA) treatments had failed, underscoring MWA's potential as a vital treatment alternative.","length":677,"tagName":"p"},{"type":"text","content":"Based on his extensive clinical evidence, Dr. Kandil concluded, "Mic...

More updates from Baird Medical Investment Holdings Ltd

Baird MedicalBaird Medical Investment Holdings Ltd.Microwave AblationThe CompanyTulane Medical CenterForward-Looking StatementsTulane University School of Medicineminimally invasiveBaird Medical Investment Holdings LtdRadiofrequency AblationAmerican Thyroid Association